Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08 juil. 2024 17h25 HE
|
Bionano Genomics
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under...
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05 juil. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements with healthcare-focused institutional investors for...
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
02 juil. 2024 08h00 HE
|
Bionano Genomics
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the...
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
20 juin 2024 08h00 HE
|
Bionano Genomics
Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow.
Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow
30 mai 2024 08h00 HE
|
Bionano Genomics
Bionano announces a record 39 scientific presentations and posters highlighting optical genome mapping at two upcoming global cytogenetics conferences.
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
28 mai 2024 08h00 HE
|
Bionano Genomics
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy
21 mai 2024 08h00 HE
|
Bionano Genomics
Optical genome mapping was used in three publications to successfully assess genome integrity in stem cells, CAR-T cells, and iPSCs.
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
09 mai 2024 08h00 HE
|
Bionano Genomics
Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
08 mai 2024 16h01 HE
|
Bionano Genomics
Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1 2024, which represents a 34% increase over Q1...
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024
01 mai 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern...